# A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial

> **NCT00580606** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 40 (actual)

## Conditions studied

- Food Hypersensitivity
- Hypersensitivity
- Immediate Hypersensitivity
- Peanut Hypersensitivity

## Interventions

- **DRUG:** Glycerinated peanut allergenic extract
- **DRUG:** Placebo for peanut extract (glycerin)

## Key facts

- **NCT ID:** NCT00580606
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2010-12
- **Final completion:** 2014-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00580606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00580606, "A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00580606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*